<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>12 Vascular Lab | Vascular Surgery Exam Prep</title>
  <meta name="description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  <meta name="generator" content="bookdown 0.27 and GitBook 2.6.7" />

  <meta property="og:title" content="12 Vascular Lab | Vascular Surgery Exam Prep" />
  <meta property="og:type" content="book" />
  
  <meta property="og:description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  <meta name="github-repo" content="https://github.com/adam-mdmph/VS-Board-Review" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="12 Vascular Lab | Vascular Surgery Exam Prep" />
  
  <meta name="twitter:description" content="This is an ebook version of board review content produced for Audible Bleeding: The Vascular Surgery Podcast" />
  

<meta name="author" content="Editors: Adam Johnson, MD, MPH; Matt Smith, MD, PhD; and Audible Bleeding" />



  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="152x152" href="images/apple_icon.png" />
  
<link rel="prev" href="angioaccess.html"/>
<link rel="next" href="endovascular.html"/>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.1.0/anchor-sections.css" rel="stylesheet" />
<link href="libs/anchor-sections-1.1.0/anchor-sections-hash.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.1.0/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">VS Board Review</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> About</a>
<ul>
<li class="chapter" data-level="1.1" data-path="index.html"><a href="index.html#usage"><i class="fa fa-check"></i><b>1.1</b> Usage</a></li>
<li class="chapter" data-level="1.2" data-path="index.html"><a href="index.html#comments-questions-or-contributions"><i class="fa fa-check"></i><b>1.2</b> Comments, Questions or Contributions</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="cerebrovascular.html"><a href="cerebrovascular.html"><i class="fa fa-check"></i><b>2</b> Cerebrovascular</a>
<ul>
<li class="chapter" data-level="2.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#available-guidelines"><i class="fa fa-check"></i><b>2.1</b> Available Guidelines</a></li>
<li class="chapter" data-level="2.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#presentation-and-diagnosis"><i class="fa fa-check"></i><b>2.2</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="2.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#management"><i class="fa fa-check"></i><b>2.3</b> Management</a>
<ul>
<li class="chapter" data-level="2.3.1" data-path="cerebrovascular.html"><a href="cerebrovascular.html#optimal-medical-therapy"><i class="fa fa-check"></i><b>2.3.1</b> Optimal medical therapy</a></li>
<li class="chapter" data-level="2.3.2" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-endarterectomy"><i class="fa fa-check"></i><b>2.3.2</b> Carotid endarterectomy</a></li>
<li class="chapter" data-level="2.3.3" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-artery-stenting"><i class="fa fa-check"></i><b>2.3.3</b> Carotid Artery Stenting</a></li>
<li class="chapter" data-level="2.3.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#management-of-uncommon-disease-presentations"><i class="fa fa-check"></i><b>2.3.4</b> Management of Uncommon Disease Presentations</a></li>
</ul></li>
<li class="chapter" data-level="2.4" data-path="cerebrovascular.html"><a href="cerebrovascular.html#prospective-trials---must-reads"><i class="fa fa-check"></i><b>2.4</b> Prospective Trials - MUST READS</a></li>
<li class="chapter" data-level="2.5" data-path="cerebrovascular.html"><a href="cerebrovascular.html#carotid-body-tumors-cbt"><i class="fa fa-check"></i><b>2.5</b> Carotid Body Tumors (CBT)</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html"><i class="fa fa-check"></i><b>3</b> Upper Extremity and Thoracic Outlet</a>
<ul>
<li class="chapter" data-level="3.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#anatomy-exposure-of-vessels"><i class="fa fa-check"></i><b>3.1</b> Anatomy/ Exposure of Vessels</a></li>
<li class="chapter" data-level="3.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#epidemiology-etiology-and-diagnostic-evaluation"><i class="fa fa-check"></i><b>3.2</b> Epidemiology, Etiology, and Diagnostic Evaluation</a></li>
<li class="chapter" data-level="3.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#operationsprocedures"><i class="fa fa-check"></i><b>3.3</b> Operations/Procedures</a></li>
<li class="chapter" data-level="3.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vaso-occlusive-disease"><i class="fa fa-check"></i><b>3.4</b> Vaso-occlusive disease</a></li>
<li class="chapter" data-level="3.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vasospastic-disorders"><i class="fa fa-check"></i><b>3.5</b> Vasospastic Disorders</a>
<ul>
<li class="chapter" data-level="3.5.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#iatrogenic-or-vasopressor-induced-ischemia"><i class="fa fa-check"></i><b>3.5.1</b> Iatrogenic or Vasopressor Induced Ischemia</a></li>
<li class="chapter" data-level="3.5.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#raynauds-phenomenon"><i class="fa fa-check"></i><b>3.5.2</b> Raynaud’s Phenomenon</a></li>
<li class="chapter" data-level="3.5.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#ergotism"><i class="fa fa-check"></i><b>3.5.3</b> Ergotism</a></li>
<li class="chapter" data-level="3.5.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#buergers-disease"><i class="fa fa-check"></i><b>3.5.4</b> Buerger’s Disease</a></li>
<li class="chapter" data-level="3.5.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#large-artery-vasculitis"><i class="fa fa-check"></i><b>3.5.5</b> Large Artery Vasculitis</a></li>
<li class="chapter" data-level="3.5.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#other-vasculitis-syndromes"><i class="fa fa-check"></i><b>3.5.6</b> Other Vasculitis syndromes</a></li>
</ul></li>
<li class="chapter" data-level="3.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#aneurysmal-disease"><i class="fa fa-check"></i><b>3.6</b> Aneurysmal Disease</a></li>
<li class="chapter" data-level="3.7" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#occupational-vascular-disease"><i class="fa fa-check"></i><b>3.7</b> Occupational Vascular Disease</a>
<ul>
<li class="chapter" data-level="3.7.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#hand-arm-vibration-syndrome"><i class="fa fa-check"></i><b>3.7.1</b> Hand-Arm Vibration Syndrome</a></li>
<li class="chapter" data-level="3.7.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#hypothenar-hammer-syndrome"><i class="fa fa-check"></i><b>3.7.2</b> Hypothenar hammer syndrome</a></li>
<li class="chapter" data-level="3.7.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#environmental-exposures"><i class="fa fa-check"></i><b>3.7.3</b> Environmental Exposures</a></li>
<li class="chapter" data-level="3.7.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#sports-medicine"><i class="fa fa-check"></i><b>3.7.4</b> Sports Medicine</a></li>
</ul></li>
<li class="chapter" data-level="3.8" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vascular-trauma-upper-extremity"><i class="fa fa-check"></i><b>3.8</b> Vascular Trauma-Upper Extremity</a></li>
<li class="chapter" data-level="3.9" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#compression-syndromes"><i class="fa fa-check"></i><b>3.9</b> Compression Syndromes</a>
<ul>
<li class="chapter" data-level="3.9.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#quadrilateral-space-syndrome"><i class="fa fa-check"></i><b>3.9.1</b> Quadrilateral space syndrome</a></li>
<li class="chapter" data-level="3.9.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#humeral-head-compression-of-axillary-artery"><i class="fa fa-check"></i><b>3.9.2</b> Humeral head compression of axillary artery</a></li>
</ul></li>
<li class="chapter" data-level="3.10" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#thoracic-outlet-syndrome"><i class="fa fa-check"></i><b>3.10</b> Thoracic Outlet Syndrome</a>
<ul>
<li class="chapter" data-level="3.10.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#anatomy"><i class="fa fa-check"></i><b>3.10.1</b> Anatomy</a></li>
<li class="chapter" data-level="3.10.2" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#diagnosis-and-evaluation"><i class="fa fa-check"></i><b>3.10.2</b> Diagnosis and Evaluation</a></li>
<li class="chapter" data-level="3.10.3" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#rib-resection-approaches"><i class="fa fa-check"></i><b>3.10.3</b> Rib Resection approaches</a></li>
<li class="chapter" data-level="3.10.4" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#vtos"><i class="fa fa-check"></i><b>3.10.4</b> vTOS</a></li>
<li class="chapter" data-level="3.10.5" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#atos"><i class="fa fa-check"></i><b>3.10.5</b> aTOS</a></li>
<li class="chapter" data-level="3.10.6" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#ntos"><i class="fa fa-check"></i><b>3.10.6</b> nTOS</a></li>
</ul></li>
<li class="chapter" data-level="3.11" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#lymphedema"><i class="fa fa-check"></i><b>3.11</b> Lymphedema</a>
<ul>
<li class="chapter" data-level="3.11.1" data-path="upper-extremity-and-thoracic-outlet.html"><a href="upper-extremity-and-thoracic-outlet.html#management-1"><i class="fa fa-check"></i><b>3.11.1</b> Management</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="4" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html"><i class="fa fa-check"></i><b>4</b> Abdominal Aneurysms</a>
<ul>
<li class="chapter" data-level="4.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#pathogenesis-presentation-and-risk-factors"><i class="fa fa-check"></i><b>4.1</b> Pathogenesis, presentation and risk factors</a></li>
<li class="chapter" data-level="4.2" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#evaluation-and-diagnosis"><i class="fa fa-check"></i><b>4.2</b> Evaluation and Diagnosis</a>
<ul>
<li class="chapter" data-level="4.2.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#imaging"><i class="fa fa-check"></i><b>4.2.1</b> Imaging</a></li>
</ul></li>
<li class="chapter" data-level="4.3" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#management-2"><i class="fa fa-check"></i><b>4.3</b> Management</a>
<ul>
<li class="chapter" data-level="4.3.1" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#evar"><i class="fa fa-check"></i><b>4.3.1</b> EVAR</a></li>
<li class="chapter" data-level="4.3.2" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#open-repair"><i class="fa fa-check"></i><b>4.3.2</b> Open Repair</a></li>
<li class="chapter" data-level="4.3.3" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#ruptured-aneurysms"><i class="fa fa-check"></i><b>4.3.3</b> Ruptured Aneurysms</a></li>
</ul></li>
<li class="chapter" data-level="4.4" data-path="abdominal-aneurysms.html"><a href="abdominal-aneurysms.html#iliacperipheral-aneurysms"><i class="fa fa-check"></i><b>4.4</b> Iliac/Peripheral Aneurysms</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html"><i class="fa fa-check"></i><b>5</b> Lower Extremity Occlusive Disease</a>
<ul>
<li class="chapter" data-level="5.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#pathophysiology"><i class="fa fa-check"></i><b>5.1</b> Pathophysiology</a></li>
<li class="chapter" data-level="5.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#intermittent-claudication"><i class="fa fa-check"></i><b>5.2</b> Intermittent Claudication</a>
<ul>
<li class="chapter" data-level="5.2.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#history-clinical-examination"><i class="fa fa-check"></i><b>5.2.1</b> History / Clinical Examination</a></li>
<li class="chapter" data-level="5.2.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-3"><i class="fa fa-check"></i><b>5.2.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#chronic-limb-threatening-ischemia"><i class="fa fa-check"></i><b>5.3</b> Chronic Limb Threatening Ischemia</a>
<ul>
<li class="chapter" data-level="5.3.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#etiology-and-presentation"><i class="fa fa-check"></i><b>5.3.1</b> Etiology and Presentation</a></li>
<li class="chapter" data-level="5.3.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#evaluation"><i class="fa fa-check"></i><b>5.3.2</b> Evaluation</a></li>
<li class="chapter" data-level="5.3.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-4"><i class="fa fa-check"></i><b>5.3.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.4" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#acute-limb-ischemia"><i class="fa fa-check"></i><b>5.4</b> Acute Limb Ischemia</a>
<ul>
<li class="chapter" data-level="5.4.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#presentation-and-diagnosis-1"><i class="fa fa-check"></i><b>5.4.1</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="5.4.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-5"><i class="fa fa-check"></i><b>5.4.2</b> Management</a></li>
<li class="chapter" data-level="5.4.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#compartment-syndrome"><i class="fa fa-check"></i><b>5.4.3</b> Compartment Syndrome</a></li>
</ul></li>
<li class="chapter" data-level="5.5" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#blue-toe-syndrome"><i class="fa fa-check"></i><b>5.5</b> Blue Toe Syndrome</a>
<ul>
<li class="chapter" data-level="5.5.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#etiology-and-presentation-1"><i class="fa fa-check"></i><b>5.5.1</b> Etiology and Presentation</a></li>
<li class="chapter" data-level="5.5.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#evaluation-1"><i class="fa fa-check"></i><b>5.5.2</b> Evaluation</a></li>
<li class="chapter" data-level="5.5.3" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#management-6"><i class="fa fa-check"></i><b>5.5.3</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="5.6" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#non-atheromatous-popliteal-artery-disease"><i class="fa fa-check"></i><b>5.6</b> Non-atheromatous Popliteal Artery Disease</a>
<ul>
<li class="chapter" data-level="5.6.1" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#popliteal-artery-entrapment-syndrome-paes"><i class="fa fa-check"></i><b>5.6.1</b> Popliteal Artery Entrapment Syndrome (PAES)</a></li>
<li class="chapter" data-level="5.6.2" data-path="lower-extremity-occlusive-disease.html"><a href="lower-extremity-occlusive-disease.html#cystic-adventitial-disease"><i class="fa fa-check"></i><b>5.6.2</b> Cystic Adventitial Disease</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html"><i class="fa fa-check"></i><b>6</b> Mesenteric Disease</a>
<ul>
<li class="chapter" data-level="6.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#acute-mesenteric-ischemia"><i class="fa fa-check"></i><b>6.1</b> Acute Mesenteric Ischemia</a>
<ul>
<li class="chapter" data-level="6.1.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#presentation-and-diagnosis-2"><i class="fa fa-check"></i><b>6.1.1</b> Presentation and diagnosis</a></li>
<li class="chapter" data-level="6.1.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#management-9"><i class="fa fa-check"></i><b>6.1.2</b> Management</a></li>
<li class="chapter" data-level="6.1.3" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#rare-etiologies"><i class="fa fa-check"></i><b>6.1.3</b> Rare Etiologies</a></li>
</ul></li>
<li class="chapter" data-level="6.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#chronic-mesenteric-ischemia"><i class="fa fa-check"></i><b>6.2</b> Chronic Mesenteric Ischemia</a>
<ul>
<li class="chapter" data-level="6.2.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#presentation-and-diagnosis-3"><i class="fa fa-check"></i><b>6.2.1</b> Presentation and Diagnosis</a></li>
<li class="chapter" data-level="6.2.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#management-10"><i class="fa fa-check"></i><b>6.2.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="6.3" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#mesenteric-aneurysms"><i class="fa fa-check"></i><b>6.3</b> Mesenteric Aneurysms</a>
<ul>
<li class="chapter" data-level="6.3.1" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#sma-aneurysm"><i class="fa fa-check"></i><b>6.3.1</b> SMA Aneurysm</a></li>
<li class="chapter" data-level="6.3.2" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#splenic-aneurysm"><i class="fa fa-check"></i><b>6.3.2</b> Splenic Aneurysm</a></li>
</ul></li>
<li class="chapter" data-level="6.4" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#median-arcuate-ligament-syndrome-mals"><i class="fa fa-check"></i><b>6.4</b> Median Arcuate Ligament Syndrome (MALS)</a></li>
<li class="chapter" data-level="6.5" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#sma-syndrome"><i class="fa fa-check"></i><b>6.5</b> SMA Syndrome</a></li>
<li class="chapter" data-level="6.6" data-path="mesenteric-disease.html"><a href="mesenteric-disease.html#uterine-fibroids"><i class="fa fa-check"></i><b>6.6</b> Uterine Fibroids</a></li>
</ul></li>
<li class="chapter" data-level="7" data-path="renal.html"><a href="renal.html"><i class="fa fa-check"></i><b>7</b> Renal</a>
<ul>
<li class="chapter" data-level="7.1" data-path="renal.html"><a href="renal.html#pathophysiology-1"><i class="fa fa-check"></i><b>7.1</b> Pathophysiology</a></li>
<li class="chapter" data-level="7.2" data-path="renal.html"><a href="renal.html#medical-management-and-evaluation"><i class="fa fa-check"></i><b>7.2</b> Medical Management and Evaluation</a></li>
<li class="chapter" data-level="7.3" data-path="renal.html"><a href="renal.html#operative-managment"><i class="fa fa-check"></i><b>7.3</b> Operative Managment</a>
<ul>
<li class="chapter" data-level="7.3.1" data-path="renal.html"><a href="renal.html#endovascular-therapy"><i class="fa fa-check"></i><b>7.3.1</b> Endovascular Therapy</a></li>
<li class="chapter" data-level="7.3.2" data-path="renal.html"><a href="renal.html#open-surgery"><i class="fa fa-check"></i><b>7.3.2</b> Open Surgery</a></li>
</ul></li>
<li class="chapter" data-level="7.4" data-path="renal.html"><a href="renal.html#fibromuscular-dysplasia-fmd"><i class="fa fa-check"></i><b>7.4</b> Fibromuscular Dysplasia (FMD)</a></li>
<li class="chapter" data-level="7.5" data-path="renal.html"><a href="renal.html#renal-artery-aneurysms"><i class="fa fa-check"></i><b>7.5</b> Renal Artery Aneurysms</a>
<ul>
<li class="chapter" data-level="7.5.1" data-path="renal.html"><a href="renal.html#demographics-2"><i class="fa fa-check"></i><b>7.5.1</b> Demographics</a></li>
<li class="chapter" data-level="7.5.2" data-path="renal.html"><a href="renal.html#anatomy-1"><i class="fa fa-check"></i><b>7.5.2</b> Anatomy</a></li>
<li class="chapter" data-level="7.5.3" data-path="renal.html"><a href="renal.html#presentation-2"><i class="fa fa-check"></i><b>7.5.3</b> Presentation</a></li>
<li class="chapter" data-level="7.5.4" data-path="renal.html"><a href="renal.html#management-11"><i class="fa fa-check"></i><b>7.5.4</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="7.6" data-path="renal.html"><a href="renal.html#renal-artery-dissection"><i class="fa fa-check"></i><b>7.6</b> Renal Artery Dissection</a></li>
<li class="chapter" data-level="7.7" data-path="renal.html"><a href="renal.html#renal-vein-thrombosis"><i class="fa fa-check"></i><b>7.7</b> Renal Vein Thrombosis</a>
<ul>
<li class="chapter" data-level="7.7.1" data-path="renal.html"><a href="renal.html#diagnosis-1"><i class="fa fa-check"></i><b>7.7.1</b> Diagnosis</a></li>
<li class="chapter" data-level="7.7.2" data-path="renal.html"><a href="renal.html#management-12"><i class="fa fa-check"></i><b>7.7.2</b> Management</a></li>
</ul></li>
<li class="chapter" data-level="7.8" data-path="renal.html"><a href="renal.html#renal-arteriovenous-fistula"><i class="fa fa-check"></i><b>7.8</b> Renal Arteriovenous Fistula</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html"><i class="fa fa-check"></i><b>8</b> Thoracic Aorta</a>
<ul>
<li class="chapter" data-level="8.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aortic-dissection"><i class="fa fa-check"></i><b>8.1</b> Aortic Dissection</a></li>
<li class="chapter" data-level="8.2" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#thoracoabdominal-aneurysms-taaa"><i class="fa fa-check"></i><b>8.2</b> Thoracoabdominal Aneurysms (TAAA)</a>
<ul>
<li class="chapter" data-level="8.2.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#anatomy-and-demographics"><i class="fa fa-check"></i><b>8.2.1</b> Anatomy and Demographics</a></li>
</ul></li>
<li class="chapter" data-level="8.3" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#aortopathies"><i class="fa fa-check"></i><b>8.3</b> Aortopathies</a>
<ul>
<li class="chapter" data-level="8.3.1" data-path="thoracic-aorta.html"><a href="thoracic-aorta.html#links"><i class="fa fa-check"></i><b>8.3.1</b> LINKS:</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="9" data-path="venous-disease.html"><a href="venous-disease.html"><i class="fa fa-check"></i><b>9</b> Venous Disease</a>
<ul>
<li class="chapter" data-level="9.1" data-path="venous-disease.html"><a href="venous-disease.html#chronic-venous-insufficiency"><i class="fa fa-check"></i><b>9.1</b> Chronic Venous Insufficiency</a>
<ul>
<li class="chapter" data-level="9.1.1" data-path="venous-disease.html"><a href="venous-disease.html#terminology-and-presentation"><i class="fa fa-check"></i><b>9.1.1</b> Terminology and Presentation</a></li>
<li class="chapter" data-level="9.1.2" data-path="venous-disease.html"><a href="venous-disease.html#evaluation-4"><i class="fa fa-check"></i><b>9.1.2</b> Evaluation</a></li>
<li class="chapter" data-level="9.1.3" data-path="venous-disease.html"><a href="venous-disease.html#treatment"><i class="fa fa-check"></i><b>9.1.3</b> Treatment</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="10" data-path="vascular-trauma.html"><a href="vascular-trauma.html"><i class="fa fa-check"></i><b>10</b> Vascular Trauma</a>
<ul>
<li class="chapter" data-level="10.1" data-path="vascular-trauma.html"><a href="vascular-trauma.html#peripheral"><i class="fa fa-check"></i><b>10.1</b> Peripheral</a></li>
<li class="chapter" data-level="10.2" data-path="vascular-trauma.html"><a href="vascular-trauma.html#abdominal-arterial"><i class="fa fa-check"></i><b>10.2</b> Abdominal Arterial</a></li>
<li class="chapter" data-level="10.3" data-path="vascular-trauma.html"><a href="vascular-trauma.html#abdominal-venous"><i class="fa fa-check"></i><b>10.3</b> Abdominal Venous</a></li>
<li class="chapter" data-level="10.4" data-path="vascular-trauma.html"><a href="vascular-trauma.html#cerebrovascular-trauma"><i class="fa fa-check"></i><b>10.4</b> Cerebrovascular Trauma</a></li>
<li class="chapter" data-level="10.5" data-path="vascular-trauma.html"><a href="vascular-trauma.html#endovascular-approaches"><i class="fa fa-check"></i><b>10.5</b> Endovascular Approaches</a></li>
</ul></li>
<li class="chapter" data-level="11" data-path="angioaccess.html"><a href="angioaccess.html"><i class="fa fa-check"></i><b>11</b> Angioaccess</a>
<ul>
<li class="chapter" data-level="11.1" data-path="angioaccess.html"><a href="angioaccess.html#planning-and-selecting-access-site"><i class="fa fa-check"></i><b>11.1</b> Planning and selecting access site</a></li>
<li class="chapter" data-level="11.2" data-path="angioaccess.html"><a href="angioaccess.html#techniques-for-fistula-creation"><i class="fa fa-check"></i><b>11.2</b> Techniques for fistula creation</a></li>
<li class="chapter" data-level="11.3" data-path="angioaccess.html"><a href="angioaccess.html#maintenance-and-complications"><i class="fa fa-check"></i><b>11.3</b> Maintenance and complications</a>
<ul>
<li class="chapter" data-level="11.3.1" data-path="angioaccess.html"><a href="angioaccess.html#failure-to-mature"><i class="fa fa-check"></i><b>11.3.1</b> Failure to mature</a></li>
<li class="chapter" data-level="11.3.2" data-path="angioaccess.html"><a href="angioaccess.html#access-failure"><i class="fa fa-check"></i><b>11.3.2</b> Access Failure</a></li>
<li class="chapter" data-level="11.3.3" data-path="angioaccess.html"><a href="angioaccess.html#sec-steal-syndrome"><i class="fa fa-check"></i><b>11.3.3</b> Steal Syndrome</a></li>
<li class="chapter" data-level="11.3.4" data-path="angioaccess.html"><a href="angioaccess.html#perioperative-neuropraxia"><i class="fa fa-check"></i><b>11.3.4</b> Perioperative neuropraxia</a></li>
<li class="chapter" data-level="11.3.5" data-path="angioaccess.html"><a href="angioaccess.html#bleeding-and-aneurysm"><i class="fa fa-check"></i><b>11.3.5</b> Bleeding and Aneurysm</a></li>
</ul></li>
<li class="chapter" data-level="11.4" data-path="angioaccess.html"><a href="angioaccess.html#dialysis-catheters"><i class="fa fa-check"></i><b>11.4</b> Dialysis Catheters</a></li>
<li class="chapter" data-level="11.5" data-path="angioaccess.html"><a href="angioaccess.html#peritoneal-dialysis"><i class="fa fa-check"></i><b>11.5</b> Peritoneal Dialysis</a></li>
</ul></li>
<li class="chapter" data-level="12" data-path="vascular-lab.html"><a href="vascular-lab.html"><i class="fa fa-check"></i><b>12</b> Vascular Lab</a>
<ul>
<li class="chapter" data-level="12.1" data-path="vascular-lab.html"><a href="vascular-lab.html#overview"><i class="fa fa-check"></i><b>12.1</b> <strong>Overview</strong></a>
<ul>
<li class="chapter" data-level="12.1.1" data-path="vascular-lab.html"><a href="vascular-lab.html#waveforms"><i class="fa fa-check"></i><b>12.1.1</b> Waveforms</a></li>
</ul></li>
<li class="chapter" data-level="12.2" data-path="vascular-lab.html"><a href="vascular-lab.html#extracranial"><i class="fa fa-check"></i><b>12.2</b> Extracranial</a></li>
<li class="chapter" data-level="12.3" data-path="vascular-lab.html"><a href="vascular-lab.html#intracranial"><i class="fa fa-check"></i><b>12.3</b> Intracranial</a></li>
<li class="chapter" data-level="12.4" data-path="vascular-lab.html"><a href="vascular-lab.html#upper-extremity"><i class="fa fa-check"></i><b>12.4</b> Upper Extremity</a>
<ul>
<li class="chapter" data-level="12.4.1" data-path="vascular-lab.html"><a href="vascular-lab.html#hemodialysis-access"><i class="fa fa-check"></i><b>12.4.1</b> Hemodialysis Access</a></li>
</ul></li>
<li class="chapter" data-level="12.5" data-path="vascular-lab.html"><a href="vascular-lab.html#lower-extremity"><i class="fa fa-check"></i><b>12.5</b> Lower Extremity</a>
<ul>
<li class="chapter" data-level="12.5.1" data-path="vascular-lab.html"><a href="vascular-lab.html#pathologies"><i class="fa fa-check"></i><b>12.5.1</b> Pathologies</a></li>
</ul></li>
<li class="chapter" data-level="12.6" data-path="vascular-lab.html"><a href="vascular-lab.html#abdominal"><i class="fa fa-check"></i><b>12.6</b> Abdominal</a>
<ul>
<li class="chapter" data-level="12.6.1" data-path="vascular-lab.html"><a href="vascular-lab.html#aorta"><i class="fa fa-check"></i><b>12.6.1</b> Aorta</a></li>
<li class="chapter" data-level="12.6.2" data-path="vascular-lab.html"><a href="vascular-lab.html#mesenteric-vasculature"><i class="fa fa-check"></i><b>12.6.2</b> Mesenteric Vasculature</a></li>
</ul></li>
<li class="chapter" data-level="12.7" data-path="vascular-lab.html"><a href="vascular-lab.html#venous"><i class="fa fa-check"></i><b>12.7</b> Venous</a></li>
<li class="chapter" data-level="12.8" data-path="vascular-lab.html"><a href="vascular-lab.html#artifacts"><i class="fa fa-check"></i><b>12.8</b> Artifacts</a></li>
</ul></li>
<li class="chapter" data-level="13" data-path="endovascular.html"><a href="endovascular.html"><i class="fa fa-check"></i><b>13</b> Endovascular</a>
<ul>
<li class="chapter" data-level="13.1" data-path="endovascular.html"><a href="endovascular.html#vascular-access"><i class="fa fa-check"></i><b>13.1</b> Vascular Access</a></li>
<li class="chapter" data-level="13.2" data-path="endovascular.html"><a href="endovascular.html#complications-1"><i class="fa fa-check"></i><b>13.2</b> Complications</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Vascular Surgery Exam Prep</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="vascular-lab" class="section level1 hasAnchor" number="12">
<h1><span class="header-section-number">12</span> Vascular Lab<a href="vascular-lab.html#vascular-lab" class="anchor-section" aria-label="Anchor link to header"></a></h1>
<p><strong>06 Jan 2022</strong>: <em>Alaska Pendleton, MD and Aahita Dua, MD</em></p>
<p><em>Acknowledgements: A special thanks to Drena Root, Technical Director at
the Massachusetts General Hospital Vascular Center, without whom this
imaging would not have been possible.</em></p>
<audio controls> <source src='https://traffic.libsyn.com/audiblebleeding/E7_-_Carotid_VSITE.mp3' type='audio/mpeg'> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio>
<p>So let’s start with an overview of ultrasound modalities, waveforms, and
changes proximal and distal to flow-limiting stenosis:</p>
<div id="overview" class="section level2 hasAnchor" number="12.1">
<h2><span class="header-section-number">12.1</span> <strong>Overview</strong><a href="vascular-lab.html#overview" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><strong>Brief overview of ultrasound:</strong> Ultrasonography uses <a href="https://en.wikipedia.org/wiki/Sound_wave">sound
waves</a> with
<a href="https://en.wikipedia.org/wiki/Frequency">frequencies</a> higher than those
audible to humans. Ultrasound images are created by sending pulses of
ultrasound
into <a href="https://en.wikipedia.org/wiki/Tissue_(biology)">tissue</a> using
a <a href="https://en.wikipedia.org/wiki/Ultrasound_transducer#Use_in_medicine">probe</a>.
Reflected pulses are recorded and displayed as an image. There are many
types of ultrasound images, but two modes commonly seen in vascular
ultrasonography are B-mode and doppler:</p>
<p><strong>B-mode (Brightness) imaging</strong> is a 2-D, black and white display of
tissue <a href="https://en.wikipedia.org/wiki/Acoustic_impedance">acoustic
impedance</a>s.</p>
<p><strong>Doppler mode</strong> uses the Doppler effect to measure and visualize blood
flow.</p>
<p><strong>Spectral Doppler</strong> converts frequency shifts from moving blood to
velocities using the Doppler equation, and displays a “spectrum” of
these frequencies as Doppler waveforms.</p>
<p><strong>Color Doppler</strong> presents velocity information as a color-coded overlay
on top of a B-mode image. Duplex ultrasonography is a term commonly used
for the simultaneous presentation of B-mode and doppler data.</p>
<div id="waveforms" class="section level3 hasAnchor" number="12.1.1">
<h3><span class="header-section-number">12.1.1</span> Waveforms<a href="vascular-lab.html#waveforms" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>What do normal spectral waveforms look like?</strong></p>
<p><u>Normal spectral waveforms</u> have a brisk upstroke, sharp
peak, rapid downstroke. A “spectral window” under the waveform, that is
that black space between the spectral waveform and the 0 velocity axis,
represents the absence of lower velocities-indicative of laminar flow
within the vessel (Image 1: normal spectrum waveform)</p>
<p><img src="images/vasc_lab/Slide2.jpeg" width="180" /></p>
<p><strong>How can we differentiate low vs high resistance waveforms?</strong></p>
<p>Waveform profiles change depending upon the nature of the distal
vascular bed being supplied. Organs like the brain, kidneys, liver,
spleen, peripheral muscle during exercise, and postprandial SMA have
constant high metabolic demand, and are therefore low resistance
vascular beds. <u>Low resistance waveforms</u> for arteries
supplying these organs demonstrate constant forward flow throughout the
cardiac cycle because the distal bed being supplied has low resistance
leading to high end-diastolic flow.</p>
<p><img src="images/vasc_lab/Slide3.jpeg" width="180" /></p>
<p>In contrast, <u>high resistance waveforms</u> are seen for
arteries supplying resting peripheral muscles, fasted mesenteric beds
(such as the fasting SMA), and the external carotid artery. High
resistance waveforms are characterized by triphasic morphology, with a
sharp peak, early diastolic flow reversal, brief forward flow (elastic
recoil of the artery, and then no flow during the remainder of the
diastolic phase.</p>
<p><img src="images/vasc_lab/Slide4.jpeg" width="180" /></p>
<p><strong>How does flow-limiting stenosis change the waveform?</strong></p>
<p>First let’s define <u>Stenosis:</u> A hemodynamically significant
stenosis (area reduction &gt;50%) will result in a doubling of velocity
from the inflow segment to the area of maximal stenosis (velocity ratio
&gt; 2).</p>
<p><strong>Now what do waveforms look like AFTER a flow-limiting stenosis?</strong></p>
<p><u>Tardus et parvus</u> refers to a pattern of Doppler ultrasound
spectral waveform resulting from arterial stenosis. The tardus et parvus
waveform is delayed with prolonged systolic acceleration (tardus) and
diminished with a small systolic amplitude and rounded systolic peak
(parvus). This phenomenon is observed downstream from the site of
stenosis. Tardus parvus in the CFA represents upstream (iliac) stenosis.
Tardus parvus in the brachial artery likely represents upstream
(subclavian or axillary) stenosis.<span class="citation"><sup>[<a href="#ref-hwang2017" role="doc-biblioref">415</a>,<a href="#ref-pellerito2019" role="doc-biblioref">416</a>]</sup></span></p>
<p><img src="images/vasc_lab/Slide5.jpeg" width="180" /></p>
<p><strong>So what will the waveform look like BEFORE a flow-limiting stenosis?</strong></p>
<p><u>Distal stenosis:</u> Distal occlusive disease will result in a
high resistance waveform, with absent diastolic flow. (Image 5: Distal
stenosis with absent diastolic flow)</p>
<p><img src="images/vasc_lab/Slide6.jpeg" width="180" /></p>
<p>Now that we’ve covered the basics, let’s move through by organ- system
high-yield vascular lab studies, findings, and pathologies.We’ll start
with the extracranial evaluation, a highly-tested area of vascular
ultrasonography.</p>
<p><strong>Ultrasound compared to other diagnostic modalities</strong></p>
<p>Duplex is often adequate to visualize any peripheral arterial bed, even
the aorta and iliacs.<span class="citation"><sup>[<a href="#ref-muelaméndez2018" role="doc-biblioref">417</a>]</sup></span></p>
<ul>
<li><p>CT - limitations include ionizing radiation, iodinated contrast and
not appropriate in patients with CKD.</p></li>
<li><p>MRA - performed with gadolinium-based contrast and not appropriate
in patients with ESRD.</p></li>
</ul>
</div>
</div>
<div id="extracranial" class="section level2 hasAnchor" number="12.2">
<h2><span class="header-section-number">12.2</span> Extracranial<a href="vascular-lab.html#extracranial" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><strong>What does a typical extracranial evaluation involve?</strong></p>
<p>Examine CCA (2 views), ICA (2 views), ECA, vertebral arteries</p>
<p><strong>What are normal ICA and ECA waveforms?</strong></p>
<p><u>Normal ECA vs ICA waveform:</u> The external carotid artery
waveform reflects a high resistance vascular bed. This means minimal
diastolic flow. Conversely, the ICA waveform reflects a low resistance
vascular bed with antegrade diastolic flow.</p>
<p><img src="images/vasc_lab/Slide7.jpeg" width="180" /></p>
<p>This makes sense, as the ICA is supplying the brain while the ECA is
supplying the face. Intuitively, the common carotid artery  is a mixture
of the ICA and ECA waveform morphologies. Like the ICA with forward flow
throughout diastole, but less as compared to the ICA due to the high
resistance influence of the ECA.</p>
<p>Another way of differentiating the external and internal carotid
arteries is the “temporal tap”. Tapping on the superficial temporal
artery (a branch of the ECA) will be transmitted as small pulsations in
the diastolic component of the external carotid artery.</p>
<p><img src="images/vasc_lab/Slide8.jpeg" width="180" /></p>
<p><strong>Can you talk about diagnostic criteria for ICA stenosis?</strong></p>
<p><u>Parameters for ICA stenosis</u>: These are a few numbers that
are (unfortunately) essential to memorize for the VSITE and RPVI.</p>
<p>Although criteria differ between guidelines, the Carotid Consensus
Criteria, define ICA stenosis &gt;= 70% as a peak systolic velocity &gt;=
230 cm/sec, EDV &gt; 100 cm/sec, and ICA/CCA ratio &gt; 4.0. Of note,
post-stenting criteria vary from pre-stenting criteria. Stenosis
criteria are not clearly defined for the CCA or ECA.</p>
<p><img src="images/vasc_lab/Slide9.jpeg" width="180" /></p>
<p><strong>When is surgery indicated for ICA stenosis?</strong></p>
<p><u>Parameters for when surgery indicated:</u></p>
<p>Asymptomatic Carotid Atherosclerosis Study (ACAS) &gt;60% stenosis
asymptomatic, NASCET &gt;50% stenosis symptomatic</p>
<p><strong>Let’s talk about other pathologies that can be visualized on
extracranial ultrasound:</strong></p>
<p><u>Pathologies:</u> Stenosis (plaque), dissection (flap),
aneurysms (rare), occlusion (no flow, do not operate), carotid body
tumor (splaying of ECA/ICA, fed by ECA branches), FMD.</p>
<p>FMD is frequently encountered on the VSITE/RPVI. How would this appear
on the exams?</p>
<p><u>Fibromuscular dysplasia</u> of the internal carotid arteries
affects women more commonly than men. Duplex findings show a “chain of
lakes” appearance, demonstrative of multiple septa and small aneurysms.
Velocity elevations and increased turbulence in the waveform patterns is
typically found on Doppler interrogation.</p>
<p><img src="images/vasc_lab/Slide10.jpeg" width="180" /></p>
<p><strong>How to treat?</strong></p>
<p>Aspirin if asymptomatic, POBA if symptomatic.</p>
<p><strong>Are there other frequently tested pathologies demonstrated on
extracranial exam?</strong></p>
<p><u>Subclavian steal:</u> Subclavian steal occurs when a proximal
subclavian stenosis or occlusion leads to reversal of vertebral artery
flow. This causes “stealing” of  blood from the posterior cerebral
circulation, and presents as vertebrobasilar insufficiency. How does
this look on duplex? Normal vertebral flow looks very similar to ICA:
antegrade low resistance waveforms with constant forward flow throughout
the cardiac cycle. As subclavian stenosis progresses, one can see
mid-systolic velocity decelerations (’bunny ears”) , and with severe
steal, there is a complete reversal of flow in the vertebral artery
towards the arm rather than towards the brain.</p>
<p><img src="images/vasc_lab/Slide11.jpeg" width="180" /></p>
<p><u>Innominate stenosis:</u> A phenomenon that is related to this,
is innominate stenosis. Here again the patient will present with
vertebrobasilar insufficiency, indicative of diminished vertebral
antegrade flow, but additionally will experience right hemispheric
insufficiency secondary to diminished R ICA antegrade flow. The
right-side duplex will demonstrate flow reversal in the vertebral
artery, abnormal waveforms in the subclavian, as well as steal pattern
waveforms in the common and internal carotid arteries. The common
denominator for all of these findings is significant disease in the
innominate artery.</p>
<p><strong>What other extracranial arteries of the head and neck can be evaluated
separately?</strong></p>
<p><u>Temporal arteritis</u> - well visualized with high frequency
transducer (10 MHz or greater). Pathognomonic halo effect of
anechoic/hypoechoic edemetous tissue surrounding the lumen due to
concentric inflammation.<span class="citation"><sup>[<a href="#ref-ball2010" role="doc-biblioref">418</a>,<a href="#ref-schmidt2014" role="doc-biblioref">419</a>]</sup></span></p>
</div>
<div id="intracranial" class="section level2 hasAnchor" number="12.3">
<h2><span class="header-section-number">12.3</span> Intracranial<a href="vascular-lab.html#intracranial" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>So that covers extracranial vascular lab evaluation. What about
intracranial? This is less frequently tested, so we will discuss just a
brief overview of views and some of the more commonly tested
pathologies.</p>
<p><u><strong>Intracranial:</strong></u></p>
<ul>
<li><p>Three primary views: temporal, foraminal (occipital), orbital views</p>
<ul>
<li><p><strong>Temporal view:</strong> Used to interrogate PCA, ACA, MCA, and ICA.
The MCA, ICA and PCA flow direction is towards the probe, the ,
The ACA flow direction is AWAY.</p></li>
<li><p><strong>Occipital view:</strong> Basilar and vertebral arteries (both away).</p></li>
<li><p><strong>Orbital view:</strong> Ophthalmic and ICA</p></li>
<li><p>Arteries differentiated by depth. MCA 3-6 cm, everything else
deeper.</p></li>
</ul></li>
</ul>
<p><strong>What are some frequently tested pathologies that are identified on
TCD?</strong></p>
<p>Indications often tested:</p>
<ul>
<li><p><u>MCA spasm (severe PSV&gt;200)</u>: Can be seen in sickle
cell disease with studies indicating a strong correlation between
mean velocities of &gt;200cm/s and the rate of stroke in children with
sickle cell disease. With blood transfusions, stroke risk can be
reduced from &gt;10% to &lt;1% per year.<span class="citation"><sup>[<a href="#ref-bulasTranscranialDopplerTCD2000" role="doc-biblioref">420</a>]</sup></span></p></li>
<li><p><u>Cerebral ischemia during CEA:</u> Comparing transcranial
Doppler sonography, near-infrared spectroscopy, stump pressure
measurement, and somatosensory evoked potentials, cerebral ischemia
was most accurately predicted by the percent change in transcranial
Doppler detected middle cerebral artery velocity. Detection of a
greater than 50% drop in middle cerebral artery velocity using
transcranial Doppler is 100% sensitive for detecting cerebral
ischemia.<span class="citation"><sup>[<a href="#ref-moritzAccuracyCerebralMonitoring2007" role="doc-biblioref">421</a>]</sup></span></p></li>
<li><p>TCD can also demonstrate microemboli (high spikes on spectral
doppler) during CEA</p></li>
</ul>
</div>
<div id="upper-extremity" class="section level2 hasAnchor" number="12.4">
<h2><span class="header-section-number">12.4</span> Upper Extremity<a href="vascular-lab.html#upper-extremity" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>Having covered head and neck vasculature, let’s move on to peripheral
vasculature. This is a huge area both on the VSITE/RPVI and in practice.
In this section we’ll cover first the upper, then the lower extremity
vasculature.</p>
<p><strong>So first, what are characteristics of waveforms in the peripheral
vasculature?</strong></p>
<p><u>Peripheral</u>: Normal waveforms are indicative of high
resistance distal beds, so we would expect triphasic waveforms</p>
<p><strong>What are normal arterial parameters in the upper extremities?</strong></p>
<p>Normal pressure gradient between the right and left brachial pressures
is &lt;20 mmHg. Normal finger pressure is &gt;80% of the ipsilateral
brachial systolic pressure. Digital brachial index &lt;0.8 is abnormal and
&lt;0.5 is diagnostic of ischemia. Absolute digital pressure &lt;70mmHg is
abnomal and &lt;60mmHg is diagnostic for ischemia. A gradient between
digits of &gt;15 mmHg is considered abnormal. These criteria are used in
occlusive disease and steal syndrome.<span class="citation"><sup>[<a href="#ref-chloros2008" role="doc-biblioref">422</a>,<a href="#ref-sen2016" role="doc-biblioref">423</a>]</sup></span></p>
<p><strong>Let’s talk about some of the most frequently tested pathologies,
starting with arterial TOS.</strong></p>
<p><u>Arterial TOS:</u> Results from compression of the subclavian
artery at the level of the first rib within the scalene triangle.
Arterial TOS testing is done by placing a sensor, most often
photoplethysmography (PPG), on one finger of each hand, recording the
resting waveforms and then recording while during maneuvers to evoke
arterial compression in the thoracic outlet.<span class="citation"><sup>[<a href="#ref-size2013" role="doc-biblioref">424</a>]</sup></span></p>
<p><strong>Can you tell us a little more about PPG testing?</strong></p>
<p><u>Photoplethysmography (PPG)</u> uses an infrared light to
illuminate superficial tissue. The reflection is received by a
photosensor, and amplitude of the reflected light is proportional to the
volume of red blood cells in the sample area. A normal digital arterial
PPG has a brisk upstroke with a narrow systolic peak, and a dicrotic
notch on the downslope during diastole.<span class="citation"><sup>[<a href="#ref-carter2001" role="doc-biblioref">425</a>]</sup></span></p>
<p><img src="images/vasc_lab/Slide12.jpeg" width="180" /></p>
<p>Digital PPGs change with progression of peripheral vascular disease. The
first changes are a loss of amplitude and loss of the dicrotic notch.
More advanced disease findings include a flattened systolic peak and a
prolonged upstroke. Significant arterial TOS is suggested when there is
a loss or persistent flattening of the digit waveforms during any of the
positional changes that can compress the subclavian artery (either with
the clavicle, first rib and scalene muscle). However, it should be noted
that up to one-third of patients without arterial TOS may have some
degree of subclavian artery compression with positional maneuvers.</p>
<p><strong>What are other diseases affecting the upper extremity?</strong></p>
<p><u>Raynaud’s:</u> Vasospastic disorder characterized by temporary
vasospasm. Diagnosis may be assisted by decrease in digital waveforms
with immersion of the hand in cold water.</p>
<p><u>Thromboangiitis obliterans:</u> Is a segmental
non-atherosclerotic inflammatory disorder characterized by
microthrombosis that primarily involves the small- and medium-sized
arteries. Ultrasonography may demonstrate the classical “corkscrew”
collateral development at the level of occlusion. TA has a male
predominance and first line treatment is smoking cessation.</p>
<div id="hemodialysis-access" class="section level3 hasAnchor" number="12.4.1">
<h3><span class="header-section-number">12.4.1</span> Hemodialysis Access<a href="vascular-lab.html#hemodialysis-access" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>Before we segue to the lower extremities, this is a good time to discuss
an entity frequently tested on the VSITE, and that constitutes for many
vascular surgeons a notable portion of their practice, and that is
hemodialysis access, and specifically fistulas.</p>
<p><u>Fistulas</u>: Ultrasound is one of the key modalities used in
identifying suitable anatomy for fistula placement, suitability of a
fistula for dialysis, and finally complications of fistulas.</p>
<p><strong>So first, assessment for fistula placement:</strong></p>
<p>The optimal configuration for an AVF is determined on the basis of vein
mapping and noninvasive studies. Veins should measure &gt;3 mm in diameter
(&gt;2.5 mm may be acceptable, as veins are likely to dilate under
anesthesia), and there should be no arterial inflow stenosis or venous
outflow stenosis. Duplex ultrasound arterial imaging can be performed at
the same time as vein mapping and can provide important predictors of
fistula maturation, such as arterial diameter and flow. The minimal
arterial lumen diameter is 2 mm.</p>
<p><strong>How can we tell if a fistula is ready to be used for hemodialysis
access?</strong></p>
<p>Rule of 6’s: At six weeks post-creation the diameter of the fistula
should be at least 6 mm and the depth no more than 0.6 cm. The flow rate
should be at least 600mL/min, and the length of the fistula should be 6
cm to allow for a successful two-needle dialysis.</p>
<p>Brachial artery volume flow rate (VFR) is one of the best measurements
to identify poor fistula maturation. &gt;800 ml/min is ideal, but &gt;600 is
often sufficient.<span class="citation"><sup>[<a href="#ref-ko2015" role="doc-biblioref">426</a>]</sup></span></p>
<p><strong>What do normal fistula spectral waveforms look like?</strong></p>
<p><u>Waveform:</u> The arterial waveform should demonstrate very
low resistance throughout diastole. End diastolic velocity should be one
half to two thirds of peak systolic velocity in a well-functioning
fistula. As a side note, this is also what one would see in an
iatrogenic arteriovenous fistula, as between the femoral artery and
vein.<span class="citation"><sup>[<a href="#ref-teodorescu2012" role="doc-biblioref">427</a>]</sup></span></p>
<p><strong>Let’s discuss commonly encountered complications and pathologies
identified in association with fistulas:</strong></p>
<p><u>Pseudoaneurysms:</u> Pseudoaneurysms commonly occur when a
puncture fails to seal and the blood is contained by the surrounding
soft tissue. As in other locations, pseudoaneurysms are defined on
imaging by a communicating neck between the arterial vessel and
pseudoaneurysmal sac with “to-and-fro” waveform at duplex.<span class="citation"><sup>[<a href="#ref-mahmoud2015" role="doc-biblioref">428</a>]</sup></span>
While small pseudoaneurysms can be managed without intervention or
surgery, larger pseudoaneurysms, pseudoaneurysms associated with
infection or overlying skin changes or bleeding may require excision and
repair.<span class="citation"><sup>[<a href="#ref-bandyk2013" role="doc-biblioref">429</a>]</sup></span></p>
<p><u>Steal syndrome:</u> Hemodialysis-related steal, also known as
access-related hand ischemia, which may occur in over half of all
patients undergoing access creation. Steal is characterized by
retrograde diastolic flow distal to the donor artery. Of note, reversal
of flow in and of itself is not sufficient to cause distal ischemia with
an intact palmar arch. This is commonly seen after access creation and
represents physiologic steal phenomenon, rather than symptomatic steal
syndrome. Digital pressures &lt;60 mm Hg are highly sensitive and specific
for predicting steal. Patients who have no symptoms (Grade 1
access-related hand ischemia), may be closely monitored without any
intervention.</p>
<p><strong>How do we treat more severe steal?</strong></p>
<p>Flow rate measurements of the fistula can help determine the optimal
treatment (banding, revision using distal inflow, distal
revascularization with interval ligation, proximalization of arterial
inflow or ligation of the fistula). For more on steal, see
<a href="angioaccess.html#sec-steal-syndrome">11.3.3</a></p>
<p><strong>So steal can occur in the context of high fistula output, can we talk
a bit about low fistula flow, as from stenosis?</strong></p>
<p><u>Central venous stenosis:</u> Venous outflow stenosis is the
most common reason for arteriovenous graft failure. A low flow rate
results in recirculation during the dialysis session. Venous obstruction
manifests as arm swelling, and with central venous stenosis may present
with collateral development over the upper extremity and chest wall.</p>
<p><u>Stenosis of fistula:</u> Arterial and mid-graft stenosis can
also cause complications, but are less common than venous stenosis.
Stenosis on imaging will be represented by narrowing of luminal diameter
of 50% (which correlates to a 75% reduction in cross-sectional area) on
b-mode ultrasound, PSV&gt;400, Vr &gt;2,5, high-resistance waveform proximal
to the stenosis, and tardus parvus waveform distal to the
stenosis.<span class="citation"><sup>[<a href="#ref-bandyk2013" role="doc-biblioref">429</a>]</sup></span></p>
</div>
</div>
<div id="lower-extremity" class="section level2 hasAnchor" number="12.5">
<h2><span class="header-section-number">12.5</span> Lower Extremity<a href="vascular-lab.html#lower-extremity" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><strong>Can you please tell us about some of the diagnostic modalities that
are used to examine perfusion in the lower extremities?</strong></p>
<p><u>ABIs:</u> Ankle-brachial index measurement requires
calculating the ratio of the highest ankle systolic pressure (posterior
tibial artery or dorsalis pedis) over the highest brachial systolic
pressure. Regardless of whether you’re doing the R or L ABI, use the
higher arm pressure for both ratios. Normal ABI &gt;0.9, severe disease
indicated by ABI&lt;0.5, and CLI by ABI&lt;0.3.</p>
<p>The ankle-brachial index in diabetic patients is frequently unreliable
due to incompressibility of the tibial vessels at the level of the cuff
secondary to calcification. Consequently, toe pressures are mandatory in
all patients with diabetes mellitus. Normal TBI&gt;0.7.</p>
<p>Of note, monophasic waveforms in the brachial artery likely represent
proximal occlusive disease in the upper extremity and therefore make the
ABI non-diagnostic because the upper extremity blood pressure is not
likely not representative of central blood pressure.<span class="citation"><sup>[<a href="#ref-chen2014" role="doc-biblioref">430</a>]</sup></span></p>
<p><u>TcPO2:</u> When there is significant tissue loss, preventing
TBI measurement, another option is transcutaneous oximetry
(TcPO2).<span class="citation"><sup>[<a href="#ref-mills2014" role="doc-biblioref">431</a>]</sup></span> Transcutaneous oximetry is a non-invasive method of
measuring the tissue partial pressure of oxygen through a heated sensor
on the skin. A TcPO2 value of 40 mmHg is the critical value below which
wound healing is impaired and ischemia develops.</p>
<p><strong>Are there other non-invasive ways of determining extremity
perfusion?</strong></p>
<p><u>PVRs:</u> Pulse volume recordings. Normal PVR waveforms have a
rapid upstroke, sharp peak, prominent dicrotic notch and downslope.
Typically 4 cuffs. High thigh cuff should be 30% greater than brachial
pressure, hence a thigh-brachial index of 1.3 is normal. However,
ABI/PVRs may not demonstrate significantly abnormal values/waveforms in
individuals with single level disease.</p>
<p><img src="images/vasc_lab/Slide13.jpeg" width="180" /></p>
<p><u>Exercise Test:</u> During exercise testing, patients are
placed on a treadmill after baseline resting ABIs are measured. The
patient is then asked to walk for 5 minutes or until physical discomfort
requires test cessation. The point when patient reports pain starts is
the initial claudication distance and the point where the patient stops
is defined as the absolute claudication distance. Diagnostic criteria
for a positive test include a drop-in ankle pressure of greater than 20
mmHg from baseline, drop in ABI greater than 0.2 from baseline, or
inability of ankle pressures to return to baseline after 3
minutes.<span class="citation"><sup>[<a href="#ref-strandness1964" role="doc-biblioref">432</a>]</sup></span></p>
<p><strong>So just to briefly summarize, what are parameters associated with poor
wound healing?</strong></p>
<p><u>Parameters associated with poor wound healing:</u> Considering
these various testing modalities, what are factors associated with poor
likelihood of wound healing? An ankle pressure &lt;50 mmHg, ABI &lt; 0.40,
TcPO2 &lt;20 mmHg, or a toe pressure &lt;20 mmHg are considered predictive
of non-healing.</p>
<p><strong>What is the utility of duplex in diagnosing lower extremity occlusive
disease?</strong></p>
<p>Duplex ultrasound is utilized to further delineate the anatomy, level
and severity of occlusive disease. Increased PSV can identify the site
of a hemodynamically significant stenosis. Diminished waveforms often
suggest more proximal disease.</p>
<p>Of note, diffuse narrowing of the SFA can result in tardus et parvus
waveforms in the popliteal, without necessarily demonstrating any areas
of high velocity.<span class="citation"><sup>[<a href="#ref-pellerito2019" role="doc-biblioref">416</a>,<a href="#ref-aburahma2022" role="doc-biblioref">433</a>]</sup></span></p>
<p><strong>Ultrasound is frequently used for graft surveillance. Can you talk
about graft surveillance parameters?</strong></p>
<p>Suggested bypass vein graft surveillance with ABI, clinical exam and
duplex should begin immediately after surgery and then continues at 3,
6, and 12 months and then every 6 to 12 months thereafter.<span class="citation"><sup>[<a href="#ref-zierler2018" role="doc-biblioref">255</a>,<a href="#ref-conte2006" role="doc-biblioref">434</a>]</sup></span> A velocity ratio (Vr) is often utilized in graft
surveillance and is defined as the peak systolic velocity (PSV) at the
site of a stenosis divided by the PSV in a normal vessel segment
proximal to the stenosis.</p>
<ul>
<li><p>The highest risk for graft thrombosis, and highest cause for concern
is suggested by PSV &gt;300 cm/s, Vr &gt;3.5, a mid-graft flow velocity
&lt;45 cm/s or a drop in ABI &gt;0.15.<span class="citation"><sup>[<a href="#ref-bandykHemodynamicsVeinGraft1988" role="doc-biblioref">435</a>]</sup></span></p></li>
<li><p>Increased risk grafts have a PSV 180-300 cm/s and a Vr 2.0-3.5.</p></li>
<li><p>Spectral pulse wave doppler is more sensitive than color doppler to
identify low flow states or thrombosed grafts.<span class="citation"><sup>[<a href="#ref-hedrick2005" role="doc-biblioref">436</a>]</sup></span></p></li>
</ul>
<p>Intervention for recurrent vein bypass graft stenosis early after
angioplasty may be best treated with an open revision and patch
plasty.<span class="citation"><sup>[<a href="#ref-jongsma2016" role="doc-biblioref">437</a>]</sup></span></p>
<p>Presenting with new swelling, pain and fluid around a prosthetic graft
on duplex ultrasound may be a sign of underlying graft infection. PET
and WBC scans may be positive up to 4mo after implantation, so do not
provide much utility in the early post-operative period.<span class="citation"><sup>[<a href="#ref-puges2019" role="doc-biblioref">438</a>]</sup></span></p>
<p><strong>Are there any considerations we need to understand when assessing a
stented vessel with ultrasound?</strong></p>
<p>Stenting decreases vessel compliance and increases observed velocities.
There is no defined consensus, but <u>in-stent restenosis</u> is
classified by some as follows:</p>
<ul>
<li><p>&gt;50% - Vr &gt;1.5 or PSV &gt;200</p></li>
<li><p>&gt;80% - Vr &gt; 3.5 or PSV &gt;275</p></li>
</ul>
<p>It should be noted that restenosis of stents vs vein grafts will have
higher velocity for the same percentage of stenosis. Tardus et parvus
waveforms distal to a stent should raise concern that stenosis is
hemodynamically significant.<span class="citation"><sup>[<a href="#ref-baril2009" role="doc-biblioref">439</a>,<a href="#ref-kawarada2013" role="doc-biblioref">440</a>]</sup></span></p>
<div id="pathologies" class="section level3 hasAnchor" number="12.5.1">
<h3><span class="header-section-number">12.5.1</span> Pathologies<a href="vascular-lab.html#pathologies" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>Let’s talk about pathologies frequently encountered in the lower
extremities:</strong></p>
<div id="psa" class="section level4 hasAnchor" number="12.5.1.1">
<h4><span class="header-section-number">12.5.1.1</span> Pseudoaneurysms (particularly femoral)<a href="vascular-lab.html#psa" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>Gray-scale ultrasonography demonstrates a hypoechoic cystic structure
adjacent to an arterial supply. Color Doppler typically demonstrates a
“yin-yang sign” within the pseudoaneurysm sac. The hallmark ultrasound
sign is identification of a neck between the sac and the feeding artery
with a “to-and-fro” spectral Doppler waveform measured at the neck. This
represents the flow in and out of the PSA during systole and diastole.</p>
<p><img src="images/vasc_lab/Slide14.jpeg" width="180" /></p>
<p>Anastomotic pseudoaneurysms develop in around 3% of femoral anastomoses
and can be associated with arterial wall weakness, endarterectomy,
mismatch between artery/graft, dilation/deterioration of graft material,
increased/uneven tension of anastamosis, underlying
infection.<span class="citation"><sup>[<a href="#ref-pellerito2019" role="doc-biblioref">416</a>]</sup></span></p>
</div>
<div id="dissections" class="section level4 hasAnchor" number="12.5.1.2">
<h4><span class="header-section-number">12.5.1.2</span> Dissections<a href="vascular-lab.html#dissections" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>Characteristic ultrasound findings on color Doppler include a parallel
blood-flow channel that separates the true and false lumen, with
diminished blood flow distally.<span class="citation"><sup>[<a href="#ref-ge2015" role="doc-biblioref">441</a>,<a href="#ref-kobayashi2018" role="doc-biblioref">442</a>]</sup></span> Traumatic
intimal flaps after knee dislocation can have a normal ABI and be
asymptomatic, but they should be followed as they can
progress.<span class="citation"><sup>[<a href="#ref-gaitini2008" role="doc-biblioref">443</a>]</sup></span> Of note, if the false lumen is filled by a
thrombus, it may not distinguishable from an intramural hematoma or
noncalcified plaque</p>
<p><img src="images/vasc_lab/Slide15.jpeg" width="180" /></p>
</div>
<div id="buerger" class="section level4 hasAnchor" number="12.5.1.3">
<h4><span class="header-section-number">12.5.1.3</span> Buerger’s Disease<a href="vascular-lab.html#buerger" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>Rare disease, but with characteristic findings on ultrasound of
serpiginous/corkscrew collaterals, occlusion of distal calf/pedal
arteries, and normal proximal arteries.<span class="citation"><sup>[<a href="#ref-busch2011" role="doc-biblioref">112</a>,<a href="#ref-fujii2011" role="doc-biblioref">113</a>]</sup></span></p>
<p>For more see <a href="upper-extremity-and-thoracic-outlet.html#buergers-disease">3.5.4</a></p>
<p><strong>There are several disease pathologies that are frequently tested
relating to the popliteal fossa. Can you talk briefly about these?</strong></p>
</div>
<div id="cad" class="section level4 hasAnchor" number="12.5.1.4">
<h4><span class="header-section-number">12.5.1.4</span> <strong>Cystic Adventitial Disease</strong><a href="vascular-lab.html#cad" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>This is a rare (but often tested) pathology. Adventitial cystic disease
is a non-atherosclerotic etiology of claudication, most often affecting
the popliteal artery in the lower extremity and leading to stenosis or
occlusion. Duplex imaging of the popliteal artery will demonstrate an
anechoic or hypoechoic <em>intraluminal</em> region with a smooth contour and
stenosis documented by velocity increase on spectral doppler.
Angiography will often show a classic “scimitar” sign - smooth well
defined crescent-shaped defect.<span class="citation"><sup>[<a href="#ref-shaw2007" role="doc-biblioref">444</a>,<a href="#ref-winn2015" role="doc-biblioref">445</a>]</sup></span></p>
<p><img src="images/vasc_lab/Slide16.jpeg" width="180" /></p>
<p>For more on adventitial cystic disease, see
<a href="lower-extremity-occlusive-disease.html#cystic-adventitial-disease">5.6.2</a>. This is not to be confused with:</p>
</div>
<div id="bakers-cyst" class="section level4 hasAnchor" number="12.5.1.5">
<h4><span class="header-section-number">12.5.1.5</span> Bakers Cyst<a href="vascular-lab.html#bakers-cyst" class="anchor-section" aria-label="Anchor link to header"></a></h4>
<p>A benign, cystic structure found in the popliteal fossa and arising from
the joint capsule. Flexion of the knee may result in compression of the
popliteal artery by the cyst. On b-mode ultrasound, a well-defined,
anechoic  cystic structure with a ‘neck’ extending into the joint space
between the semimembranosus tendon and the medial head of the
gastrocnemius will be identified.</p>
<p><img src="images/vasc_lab/Slide17.jpeg" width="180" /></p>
<p><u>Popliteal entrapment syndrome:</u> decrease in ABI or loss of
distal pulses with passive dorsiflexion or active plantar flexion of the
foot caused by compression of the popliteal artery by the gastrocnemius.</p>
</div>
</div>
</div>
<div id="abdominal" class="section level2 hasAnchor" number="12.6">
<h2><span class="header-section-number">12.6</span> Abdominal<a href="vascular-lab.html#abdominal" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<div id="aorta" class="section level3 hasAnchor" number="12.6.1">
<h3><span class="header-section-number">12.6.1</span> Aorta<a href="vascular-lab.html#aorta" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p><strong>AAA:</strong> Ultrasound screening of a AAA is non-invasive, accurate, and
cost-effective. Sensitivity of 98% and specificity of 99% for AAA
diagnosis. Size criteria for AAA repair is 5.5 cm men, 5.0-5.5 cm in
women, measured outer wall to outer wall cross-sectional diameter.</p>
<p><strong>Can ultrasound be used for graft surveillance s/p EVAR?</strong></p>
<p><u>S/p EVAR:</u> Surveillance color duplex ultrasound is safe if
CT imaging at 1 year exhibits no sac growth, graft migration, or
endoleak (or stable type II endoleak). Can detect endoleaks, sac
expansion, and limb occlusion. Migration difficult to assess given
challenge of renal arteries visualization in a long axis view of the
aorta.</p>
<p><strong>What other pathologies can be identified on ultrasound evaluation of
the abdomen?</strong></p>
<p><u>CIA aneurysms:</u> SVS defines CIA aneurysms as any permanent,
localized dilatation of the iliac artery &gt;1.5 cm in diameter (diameter
1.5x the normal diameter)</p>
<p><u>Para-anastomotic pseudoaneurysms:</u> As previously discussed
(reported in up to 0.5% to 10% of cases)</p>
<p><u>Penetrating aortic ulcers:</u> Describes an ulcerating
atherosclerotic lesion that penetrates the intima and progresses into
the media. Associated with atherosclerotic plaque on ultrasound</p>
<p><u>Dissections:</u> (as already discussed) a dissection flap is
usually identified and color flow demonstrates dual channels (true and
false lumens). Turbulent flow patterns are frequently encountered.</p>
</div>
<div id="mesenteric-vasculature" class="section level3 hasAnchor" number="12.6.2">
<h3><span class="header-section-number">12.6.2</span> Mesenteric Vasculature<a href="vascular-lab.html#mesenteric-vasculature" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<p>So far we have steered clear of the mesenteric vasculature. But this is
an area frequently encountered on exams. Let’s start with mesenteric
vessel stenosis.</p>
<p><strong>Celiac and SMA stenosis:</strong> May present as chronic mesenteric
ischemia. PSV &gt;275 cm/s in the SMA or &gt;200 cm/s in the celiac artery
indicates &gt;=70% stenosis. Normal SMA Doppler waveforms in the fasting
patient show high resistance waveform, PSV &lt;275 cm/s and no spectral
broadening. In the postprandial state, the waveform becomes low
resistance, with a slightly increased PSV and little to no spectral
broadening. Significant SMA stenosis may be differentiated by the
presence of spectral broadening and elevated PSV and EDV. Distal to the
stenosis, one would expect a tardus parvis waveform. EDV &gt;45 in SMA or
&gt;55 in celiac are predictive of stenosis (would expect higher diastolic
flow in celiac trunk given low resistance vascular bed of liver and
spleen).</p>
<p><strong>What other mesenteric vessel pathologies may be identified on vascular
ultrasound?</strong></p>
<p><u>Dissections:</u> Rare without concomitant aortic dissection.</p>
<p><u>Aneurysms:</u> Rare. Repair &gt;2 cm celiac, hepatic, SMA
aneurysms and &gt;3 cm splenic and renal.</p>
<p><u>Median arcuate ligament syndrome:</u> MALS can cause
significantly elevated velocities at the origin of the celiac artery.
Testing is for reversible mechanical compression, as opposed to a fixed
lesion from atherosclerotic disease. During deep inspiration or in the
upright position, celiac velocities should normalize if stenosis is
secondary to MALS.</p>
<p><strong>So I recognize that we are jumping ahead here discussing venous
circulation, but as this represents another component of a mesenteric
vascular exam, let’s discuss portal venous ultrasonography.</strong></p>
<p><u>Portal vein:</u> Normal portal venous flow is hepatopetal
(toward the liver), whereas abnormal portal venous flow is hepatofugal
(away from the liver). (The root “fugua” means to flee, or flight). Flow
should be in the same direction as the hepatic artery. Other
abnormalities that may be visualized are portal vein thrombosis (often
associated with portal venous hypertension in patients with chronic
cirrhosis, hepatitis, or hepatocellular carcinoma). Acute portal vein
thrombosis on ultrasound demonstrates dilatation of the portal vein with
hypoechoic intraluminal thrombus. Chronic portal vein thrombosis is
characterized by a contracted vein with heterogeneous/hyperechoic echoes
and may be associated with collateral formation.  Can also assess for
hepatic artery stenosis/thrombosis and for functioning of TIPS
(transjugular intrahepatic portosystemic shunt).</p>
<p><strong>Awesome, and so before jumping fully into venous circulation, let’s
complete our discussion of abdominal ultrasound evaluation with a
discussion of the renal vasculature.</strong></p>
<p><u>Renal Pathologies:</u> ostial (atherosclerotic) vs mid-artery
(FMD)</p>
<p><u>Atherosclerotic stenosis:</u> PSV&gt;200 cm/s predictive of
&gt;60% stenosis. Renal artery-to-aortic PSV ratio (RAR) &gt;3.5 also
correlates with a &gt;60% stenosis. The renal resistive index (RRI) is
calculated as the RA PSV-EDV/PSV. The RRI (&gt;0.8) is an indicator of
intrinsic parenchymal renal disease.</p>
<p><u>FMD:</u> As discussed for the carotids, FMD manifests as
beaded lesions in medium and small arteries, with the renal arteries the
most commonly affected. Ultrasound demonstrates increased PSV in the mid
and distal renal artery. Stenoses in the mid and distal renal artery are
suggestive of FMD, atherosclerotic disease is primarily ostial in
nature.</p>
</div>
</div>
<div id="venous" class="section level2 hasAnchor" number="12.7">
<h2><span class="header-section-number">12.7</span> Venous<a href="vascular-lab.html#venous" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p><strong>Venous Exam:</strong> Uses a linear transducer. Complete deep venous reflux
duplex examination includes color and pulsed wave spectral doppler
imaging. Spontaneous Doppler waveforms as well as provocative maneuvers
are recorded in the common femoral, femoral, popliteal, and tibial deep
veins. Superficial veins (GSV, SSV, and perforator veins) are evaluated
with provocative maneuvers to test valve competency. Diameters are also
included for superficial veins. Transverse B-mode images are used for
vessel compression (as when looking for thrombus) to ensure that the
vein is fully compressible under probe pressure as opposed to simply
slipping out of view, as may occur in longitudinal views. Reflux exam
should be performed with a patient standing, with assessment performed
on the non weight-bearing leg.</p>
<p><strong>We’ve talked extensively about normal arterial waveforms; what do
normal venous waveforms look like?</strong></p>
<p><u>Normal venous waveforms:</u> Normal flow patterns of iliac and
femoral veins demonstrate phasicity and should augment with distal
compression. In the upper extremity central veins, doppler waveforms
normally demonstrate pulsatility and phasicity.</p>
<p><strong>What does this mean? Pulsatility, phasicity, and augmentation</strong>?</p>
<p><strong>Pulsatility:</strong> Refers to changes in the venous waveform in accordance
with the cardiac cycle. Pulsatility is normal in the upper extremity
veins central veins, given their proximity to the heart.</p>
<p><img src="images/vasc_lab/Slide18.jpeg" width="180" /></p>
<p>This is an abnormal finding in the lower extremity veins, and may be a
sign of pulmonary hypertension, right heart failure, or tricuspid
regurgitation.</p>
<p><strong>Phasicity:</strong> (also called respiratory phasicity) is variation in the
waveform with respiration. This results from increasing and decreasing
intrathoracic pressures secondary to respiration. Phasicity is an
indicator of a patency proximal to the point of measurement. So if we
see lack of phasicity (continuous flow) in the left femoral vein but
normal phasicity in the right, we would be concerned for left iliac vein
occlusion or stenosis. If we saw absence of phasicity (continuous flow)
in the bilateral femoral veins, we would be concerned for IVC
obstruction or stenosis.</p>
<p><img src="images/vasc_lab/Slide19.jpeg" width="180" /></p>
<p><strong>Augmentation:</strong> Distal compression that augments forward flow. For
example, if we are measuring flow at the femoral vein and we squeeze the
calf and we see augmentation in the waveform, this indicates lack of
occlusion in the venous system from the knee to the probe.</p>
<p><img src="images/vasc_lab/Slide20.jpeg" width="180" /></p>
<p><strong>What are venous pathologies that are commonly tested/encountered?</strong></p>
<p><u>Reflux:</u> Venous reflux due to valvular incompetence is best
assessed with duplex scanning in the upright position. Reflux in the
common femoral vein and the saphenofemoral junction may be elicited with
a Valsalva maneuver (which increases intra-abdominal pressure), but
release of a pneumatic cuff compression is a more reproducible method.
Reflux is identified as reverse flow - that is, away from the heart -
following valsalva or release of the compression cuff.</p>
<p><img src="images/vasc_lab/Slide21.jpeg" width="180" /></p>
<p>Consensus guidelines suggest a cutoff value of 1 second for abnormally
reversed flow (reflux) in the femoral and popliteal veins and of 0.5
seconds for the great saphenous vein, small saphenous vein, tibial, and
deep femoral veins.</p>
<p><u>Perforator veins:</u> Perforator veins connect the deep and
superficial venous systems, penetrating the deep fascia overlying the
muscle.  Size &gt;3.5 mm and reflux &gt;350 ms (deep to superficial) is
associated with perforator reflux. Pathological perforator = in
association with a healed or non-healed ulcer.</p>
<p><strong>What are some other examples of reflux?</strong></p>
<p><u>Ovarian vein reflux:</u> The ultrasound evaluation of pelvic
congestion syndrome is performed in steep reverse Trendelenburg and
standing positions with a low-frequency probe. Reflux is identified
during the Valsalva maneuver. There are no validated criteria for the
duration of reflux. Rather, an ovarian vein diameter &gt;6 mm is
considered significant.</p>
<p><u>May Thurner</u><strong>:</strong> Also known as iliac vein compression
syndrome, refers to a chronic compression of the left <a href="https://radiopaedia.org/articles/common-iliac-vein?lang=us">common iliac
vein</a> by the
overlying right <a href="https://radiopaedia.org/articles/common-iliac-artery?lang=us">common iliac
artery</a> (CIA),
with or without <a href="https://radiopaedia.org/articles/deep-vein-thrombosis?lang=us">deep venous
thrombosis</a>.
Notably, patients present with unilateral (left) lower extremity edema
and pain, varicosities, DVT or venous ulcers. Intravascular ultrasound
will demonstrate &gt;50% stenosis of the iliac vein from compression.
Distal waveforms will demonstrate absence of phasicity if
obstruction/stenosis is severe with continuous flow.</p>
<p><strong>Ok, let’s transition from reflux to thrombosis:</strong></p>
<p><u>Thrombosis:</u> Characteristics of acute thrombus are an
echolucent and incompressible thrombus in a thin-walled vein with
significant distension.</p>
<p><img src="images/vasc_lab/Slide22.jpeg" width="180" /></p>
<p>Acute thrombus typically causes the vein to dilate with a diameter
greater than the diameter of the adjacent artery. Venous wall
thickening/scarring, a contracted vein, recanalization, and
collateralization is found in chronic thrombosis.</p>
<p><strong>Let’s discuss 2 Specific examples of venous thrombosis: VTOS and
EHIT</strong></p>
<p><u>Venous TOS:</u> Venous thoracic outlet syndrome is thrombosis
or severe stenosis of the subclavian or axillary veins secondary to
chronic extrinsic mechanical compression. Repetitive injury to the
subclavian vein at the level of the costoclavicular space results in
chronic injury to the veins. Venous duplex may show a dilated,
non-compressible vein consistent with an acute subclavian vein DVT, or
lack of pulsatility/phasicity if obstruction/stenosis is more centrally
located.</p>
<p><u>EHIT or Endovenous Heat Induced Thrombosis:</u> S/p endovenous
thermal ablations (RFA or laser ablation) of the GSV. 4 Grades: Grade 1
is thrombus in the GSV up to the level of the CFV. If &lt; 50% of the CFV
lumen is involved this is EHIT grade 2. EHIT grade 3 is extension into
the CFV occupying &gt;50% of the lumen and grade 4 is occlusion of the
CFV.</p>
<p><img src="images/vasc_lab/Slide23.jpeg" width="180" /></p>
<p>EHIT grades 3-4 are typically treated with anticoagulation to reduce
risk of PE. To minimize the risk of EHIT, the catheter should be
positioned at least 2 cm from the saphenofemoral junction.</p>
</div>
<div id="artifacts" class="section level2 hasAnchor" number="12.8">
<h2><span class="header-section-number">12.8</span> Artifacts<a href="vascular-lab.html#artifacts" class="anchor-section" aria-label="Anchor link to header"></a></h2>
<p>Finally, let’s wrap up this episode with a discussion of imaging
artifacts. These are frequently encountered and tested in vascular
ultrasound, and it is important to recognize imaging artifacts in order
to prevent incorrect interpretation.</p>
<p><strong>Acoustic shadowing:</strong> Shadowing on an ultrasound image is
characterized by a signal void behind structures that strongly absorb,
reflect, or refract ultrasonic waves.</p>
<p><img src="images/vasc_lab/Slide24.jpeg" width="180" /></p>
<p>Practically speaking, this most typically occurs deep to strongly
reflective surfaces such as calcified plaques, and appears as a “dark
area” beneath the plaque. <strong>Acoustic enhancement</strong> is essentially the
inverse situation, and appears as a “bright area” deep to structures
that transmit ultrasound waves exceptionally well. This can happen deep
to fluid-filled structures such as cysts.</p>
<p><strong>Mirroring</strong>: A mirror-image artifact is caused by reverberation of
ultrasound and shows structures that exist on one side of a strong
reflector as also being present on the other side of the reflector.</p>
<p><img src="images/vasc_lab/Slide25.jpeg" width="180" /></p>
<p>This is often seen around the pleura and the diaphragm, due to the
strong reflection of ultrasound from the air-filled lung. These
artifacts can occur in both B-mode imaging where you see the mirrored
image and Doppler, in which you see the mirrored waveform.</p>
<p><strong>Refraction:</strong> A refraction artifact is the result of ultrasound waves
passing through tissues with different propagation velocities (such as
air and water) and causes a structure to be improperly positioned
laterally in the image. This is the phenomenon that results in a straw
appearing bent when in a glass of water.</p>
<p><strong>Speed artifact:</strong> Depth determination by an ultrasound machine is
based on calculations using an average propagation velocity of sound in
soft tissue of 1540 m/s. If the ultrasound wave passes through a medium
at a different speed than predicted by the machine, an inaccurate image
depth will be displayed. If the ultrasound passes less quickly through
the material than soft tissue (as occurs in air or fluid), then the
image will be displayed deeper than the true depth. In practical
application, this is what causes a “bayonet” sign, or apparent bending
of a needle when it passes from soft tissue into a cystic structure.</p>
<p><strong>Inappropriate color gain:</strong> Overly gained images will show “speckling”
in areas in which no flow is present (such as in soft tissue).
Increasing the gain, increases both the signal and the
noise.<span class="citation"><sup>[<a href="#ref-kremkau2021" role="doc-biblioref">446</a>]</sup></span></p>
<p><img src="images/vasc_lab/Slide26.jpeg" width="180" /></p>
<p>Under-gaining will result in reduced sensitivity to low velocity flow.</p>
<p><strong>Inappropriate angle correction:</strong> Make sure the angle correction
cursor is centered in the vessel and parallel to the walls, otherwise
the Doppler velocity measurement will be incorrect.</p>
<p><img src="images/vasc_lab/Slide27.jpeg" width="180" /></p>
<p>Finally, can we talk about aliasing, as I feel like this comes up a lot
on exams:</p>
<p><strong>Aliasing:</strong> Unlike <a href="https://radiopaedia.org/articles/continuous-wave-doppler?lang=us">continuous wave
Doppler</a>,
pulsed wave and color flow Doppler are characterized by rapid pulses of
ultrasound waves (at a rate called the pulse repetition frequency).
The <a href="https://radiopaedia.org/articles/nyquist-limit?lang=us">Nyquist
limit</a> defines
the frequency at which aliasing will occur, as equal to the PRF/2. So
what does this mean practically? In pulsed wave doppler, if the velocity
of blood is greater than ½ the PRF, the peak velocity will be cut off,
and wrapped around to the bottom of the scale.</p>
<p><img src="images/vasc_lab/Slide28.jpeg" width="180" /></p>
<p>This results in inaccurate measurement of peak velocities, and may be
remedied by increasing the PRF and hence the scale. In color flow
doppler, aliasing appears as red to blue hues without separation of a
black region indicating no flow. This occurs in areas of high velocity
(such as immediately post-stenosis). This can be remedied with an
increase in the color scale. Of note, if asked to determine the
direction of blood flow in a vessel demonstrating aliasing, one should
assess the flow in low-velocity areas of blood flow, as seen along
vessel walls.</p>

</div>
</div>
<h3>References<a href="references.html#references" class="anchor-section" aria-label="Anchor link to header"></a></h3>
<div id="refs" class="references csl-bib-body hanging-indent" line-spacing="2">
<div id="ref-busch2011" class="csl-entry">
112. Busch, K. (2011). Buerger’s disease (thromboangiitis obliterans): Clinical features and assessment by colour duplex ultrasound. <em>Australasian Journal of Ultrasound in Medicine</em>, <em>14</em>(4), 18–22. <a href="https://doi.org/10.1002/j.2205-0140.2011.tb00126.x">https://doi.org/10.1002/j.2205-0140.2011.tb00126.x</a>
</div>
<div id="ref-fujii2011" class="csl-entry">
113. Fujii, Y., Soga, J., Hidaka, T., Hata, T., Idei, N., Fujimura, N., Mikami, S., Maruhashi, T., Kihara, Y., Noma, K., &amp; al., et. (2011). Color doppler flows of corkscrew collaterals in thromboangiitis obliterans (buerger’s disease) using color duplex ultrasonography. <em>Journal of the American College of Cardiology</em>, <em>57</em>(25), 2539. <a href="https://doi.org/10.1016/j.jacc.2010.07.071">https://doi.org/10.1016/j.jacc.2010.07.071</a>
</div>
<div id="ref-zierler2018" class="csl-entry">
255. Zierler, R. E., Jordan, W. D., Lal, B. K., Mussa, F., Leers, S., Fulton, J., Pevec, W., Hill, A., &amp; Murad, M. H. (2018). The society for vascular surgery practice guidelines on follow-up after vascular surgery arterial procedures. <em>Journal of Vascular Surgery</em>, <em>68</em>(1), 256–284. <a href="https://doi.org/10.1016/j.jvs.2018.04.018">https://doi.org/10.1016/j.jvs.2018.04.018</a>
</div>
<div id="ref-hwang2017" class="csl-entry">
415. Hwang, J. Y. (2017). Doppler ultrasonography of the lower extremity arteries: Anatomy and scanning guidelines. <em>Ultrasonography</em>, <em>36</em>(2), 111–119. <a href="https://doi.org/10.14366/usg.16054">https://doi.org/10.14366/usg.16054</a>
</div>
<div id="ref-pellerito2019" class="csl-entry">
416. Pellerito, J. S., &amp; Polak, J. F. (2019). <em>Introduction to vascular ultrasonography</em> (7th ed.). Elsevier.
</div>
<div id="ref-muelaméndez2018" class="csl-entry">
417. Muela Méndez, M., Morata Barrado, P. C., Blanco Cañibano, E., García Fresnillo, B., &amp; Guerra Requena, M. (2018). Preoperative mapping of the aortoiliac territory with duplex ultrasound in patients with peripheral arterial occlusive disease. <em>Journal of Vascular Surgery</em>, <em>68</em>(2), 503–509. <a href="https://doi.org/10.1016/j.jvs.2017.11.082">https://doi.org/10.1016/j.jvs.2017.11.082</a>
</div>
<div id="ref-ball2010" class="csl-entry">
418. Ball, E. L., Walsh, S. R., Tang, T. Y., Gohil, R., &amp; Clarke, J. M. F. (2010). Role of ultrasonography in the diagnosis of temporal arteritis. <em>The British Journal of Surgery</em>, <em>97</em>(12), 1765–1771. <a href="https://doi.org/10.1002/bjs.7252">https://doi.org/10.1002/bjs.7252</a>
</div>
<div id="ref-schmidt2014" class="csl-entry">
419. Schmidt, W. A. (2014). Role of ultrasound in the understanding and management of vasculitis. <em>Therapeutic Advances in Musculoskeletal Disease</em>, <em>6</em>(2), 39–47. <a href="https://doi.org/10.1177/1759720X13512256">https://doi.org/10.1177/1759720X13512256</a>
</div>
<div id="ref-bulasTranscranialDopplerTCD2000" class="csl-entry">
420. Bulas, D. I., Jones, A. M., Seibert, J. J., Driscoll, C., O’Donnell, R., &amp; Adams, R. J. (2000). Transcranial <span>Doppler</span> (<span>TCD</span>) screening for stroke prevention in sickle cell anemia: Pitfalls in technique variation. <em>Pediatric Radiology</em>, <em>30</em>(11), 733–738. <a href="https://doi.org/10.1007/s002470000317">https://doi.org/10.1007/s002470000317</a>
</div>
<div id="ref-moritzAccuracyCerebralMonitoring2007" class="csl-entry">
421. Moritz, S., Kasprzak, P., Arlt, M., Taeger, K., &amp; Metz, C. (2007). Accuracy of <span>Cerebral Monitoring</span> in <span>Detecting Cerebral Ischemia</span> during <span>Carotid Endarterectomy</span>. <em>Anesthesiology</em>, <em>107</em>(4), 563–569. <a href="https://doi.org/10.1097/01.anes.0000281894.69422.ff">https://doi.org/10.1097/01.anes.0000281894.69422.ff</a>
</div>
<div id="ref-chloros2008" class="csl-entry">
422. Chloros, G. D., Smerlis, N. N., Li, Z., Smith, T. L., Smith, B. P., &amp; Koman, L. A. (2008). Noninvasive evaluation of upper-extremity vascular perfusion. <em>The Journal of Hand Surgery</em>, <em>33</em>(4), 591–600. <a href="https://doi.org/10.1016/j.jhsa.2008.01.034">https://doi.org/10.1016/j.jhsa.2008.01.034</a>
</div>
<div id="ref-sen2016" class="csl-entry">
423. Sen, I., &amp; Tripathi, R. K. (2016). Dialysis access-associated steal syndromes. <em>Seminars in Vascular Surgery</em>, <em>29</em>(4), 212–226. <a href="https://doi.org/10.1053/j.semvascsurg.2017.04.002">https://doi.org/10.1053/j.semvascsurg.2017.04.002</a>
</div>
<div id="ref-size2013" class="csl-entry">
424. Size, G. P., Lozanski, L., Russo, T., French-Sherry, E., &amp; Skelly, C. L. (2013). <em>Inside ultrasound vascular reference guide</em>.
</div>
<div id="ref-carter2001" class="csl-entry">
425. Carter, S. A., &amp; Tate, R. B. (2001). The value of toe pulse waves in determination of risks for limb amputation and death in patients with peripheral arterial disease and skin ulcers or gangrene. <em>Journal of Vascular Surgery</em>, <em>33</em>(4), 708–714. <a href="https://doi.org/10.1067/mva.2001.112329">https://doi.org/10.1067/mva.2001.112329</a>
</div>
<div id="ref-ko2015" class="csl-entry">
426. Ko, S. H., Bandyk, D. F., Hodgkiss-Harlow, K. D., Barleben, A., &amp; Lane, J. (2015). Estimation of brachial artery volume flow by duplex ultrasound imaging predicts dialysis access maturation. <em>Journal of Vascular Surgery</em>, <em>61</em>(6), 1521–1528. <a href="https://doi.org/10.1016/j.jvs.2015.01.036">https://doi.org/10.1016/j.jvs.2015.01.036</a>
</div>
<div id="ref-teodorescu2012" class="csl-entry">
427. Teodorescu, V., Gustavson, S., &amp; Schanzer, H. (2012). Duplex ultrasound evaluation of hemodialysis access: A detailed protocol. <em>International Journal of Nephrology</em>, <em>2012</em>, 508956. <a href="https://doi.org/10.1155/2012/508956">https://doi.org/10.1155/2012/508956</a>
</div>
<div id="ref-mahmoud2015" class="csl-entry">
428. Mahmoud, M. Z., Al-Saadi, M., Abuderman, A., Alzimami, K. S., Alkhorayef, M., Almagli, B., &amp; Sulieman, A. (2015). <span>“To-and-fro”</span> waveform in the diagnosis of arterial pseudoaneurysms. <em>World Journal of Radiology</em>, <em>7</em>(5), 89–99. <a href="https://doi.org/10.4329/wjr.v7.i5.89">https://doi.org/10.4329/wjr.v7.i5.89</a>
</div>
<div id="ref-bandyk2013" class="csl-entry">
429. Bandyk, D. F. (2013). Interpretation of duplex ultrasound dialysis access testing. <em>Seminars in Vascular Surgery</em>, <em>26</em>(2-3), 120–126. <a href="https://doi.org/10.1053/j.semvascsurg.2013.12.001">https://doi.org/10.1053/j.semvascsurg.2013.12.001</a>
</div>
<div id="ref-chen2014" class="csl-entry">
430. Chen, A., Prout, D., &amp; Jain, N. (2014). Bilateral subclavian stenosis as a cause of unexplained hypotension. <em>Journal of American College of Cardiology</em>, <em>12 Supplement</em>, A698.
</div>
<div id="ref-mills2014" class="csl-entry">
431. Mills, J. L., Conte, M. S., Armstrong, D. G., Pomposelli, F. B., Schanzer, A., Sidawy, A. N., &amp; Andros, G. (2014). The society for vascular surgery lower extremity threatened limb classification system: Risk stratification based on wound, ischemia, and foot infection (WIfI). <em>Journal of Vascular Surgery</em>, <em>59</em>(1), 220–234.e2. <a href="https://doi.org/10.1016/j.jvs.2013.08.003">https://doi.org/10.1016/j.jvs.2013.08.003</a>
</div>
<div id="ref-strandness1964" class="csl-entry">
432. Strandness, D. E., &amp; Bell, J. W. (1964). AN EVALUATION OF THE HEMODYNAMIC RESPONSE OF THE CLAUDICATING EXTREMITY TO EXERCISE. <em>Surgery, Gynecology and Obstetrics</em>, <em>119</em>, 1237–1242.
</div>
<div id="ref-aburahma2022" class="csl-entry">
433. AbuRahma, A. F., &amp; Perler, B. A. (2022). <em>Noninvasive vascular diagnosis: A practical textbook for clinicians</em>.
</div>
<div id="ref-conte2006" class="csl-entry">
434. Conte, M. S., Bandyk, D. F., Clowes, A. W., Moneta, G. L., Seely, L., Lorenz, T. J., Namini, H., Hamdan, A. D., Roddy, S. P., Belkin, M., &amp; al., et. (2006). Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. <em>Journal of Vascular Surgery</em>, <em>43</em>(4), 742–751; discussion 751. <a href="https://doi.org/10.1016/j.jvs.2005.12.058">https://doi.org/10.1016/j.jvs.2005.12.058</a>
</div>
<div id="ref-bandykHemodynamicsVeinGraft1988" class="csl-entry">
435. Bandyk, D. F., Seabrook, G. R., Moldenhauer, P., Lavin, J., Edwards, J., Cato, R., &amp; Towne, J. B. (1988). <em>Hemodynamics of vein graft stenosis</em>. <em>8</em>(6), 8.
</div>
<div id="ref-hedrick2005" class="csl-entry">
436. Hedrick, W. R., Hykes, D. L., &amp; Starchman, D. E. (2005). <em>Ultrasound physics and instrumentation</em> (4th ed). Elsevier Mosby.
</div>
<div id="ref-jongsma2016" class="csl-entry">
437. Jongsma, H., Bekken, J. A., Buchem, F. van, Bekkers, W. J. J., Azizi, F., &amp; Fioole, B. (2016). Secondary interventions in patients with autologous infrainguinal bypass grafts strongly improve patency rates. <em>Journal of Vascular Surgery</em>, <em>63</em>(2), 385–390. <a href="https://doi.org/10.1016/j.jvs.2015.08.100">https://doi.org/10.1016/j.jvs.2015.08.100</a>
</div>
<div id="ref-puges2019" class="csl-entry">
438. Puges, M., Bérard, X., Ruiz, J.-B., Debordeaux, F., Desclaux, A., Stecken, L., Pereyre, S., Hocquelet, A., Bordenave, L., Pinaquy, J.-B., &amp; al., et. (2019). Retrospective study comparing WBC scan and 18F-FDG PET/CT in patients with suspected prosthetic vascular graft infection. <em>European Journal of Vascular and Endovascular Surgery</em>, <em>57</em>(6), 876–884. <a href="https://doi.org/10.1016/j.ejvs.2018.12.032">https://doi.org/10.1016/j.ejvs.2018.12.032</a>
</div>
<div id="ref-baril2009" class="csl-entry">
439. Baril, D. T., Rhee, R. Y., Kim, J., Makaroun, M. S., Chaer, R. A., &amp; Marone, L. K. (2009). Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery. <em>Journal of Vascular Surgery</em>, <em>49</em>(1), 133–139. <a href="https://doi.org/10.1016/j.jvs.2008.09.046">https://doi.org/10.1016/j.jvs.2008.09.046</a>
</div>
<div id="ref-kawarada2013" class="csl-entry">
440. Kawarada, O., Higashimori, A., Noguchi, M., Waratani, N., Yoshida, M., Fujihara, M., Yokoi, Y., Honda, Y., &amp; Fitzgerald, P. J. (2013). Duplex criteria for in-stent restenosis in the superficial femoral artery. <em>Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions</em>, <em>81</em>(4), E199–205. <a href="https://doi.org/10.1002/ccd.24509">https://doi.org/10.1002/ccd.24509</a>
</div>
<div id="ref-ge2015" class="csl-entry">
441. Ge, B. H., Copelan, A., Scola, D., &amp; Watts, M. M. (2015). Iatrogenic percutaneous vascular injuries: Clinical presentation, imaging, and management. <em>Seminars in Interventional Radiology</em>, <em>32</em>(2), 108–122. <a href="https://doi.org/10.1055/s-0035-1549375">https://doi.org/10.1055/s-0035-1549375</a>
</div>
<div id="ref-kobayashi2018" class="csl-entry">
442. Kobayashi, N., Hirano, K., Yamawaki, M., Araki, M., Sakai, T., Sakamoto, Y., Mori, S., Tsutsumi, M., Honda, Y., &amp; Ito, Y. (2018). Simple classification and clinical outcomes of angiographic dissection after balloon angioplasty for femoropopliteal disease. <em>Journal of Vascular Surgery</em>, <em>67</em>(4), 1151–1158. <a href="https://doi.org/10.1016/j.jvs.2017.08.092">https://doi.org/10.1016/j.jvs.2017.08.092</a>
</div>
<div id="ref-gaitini2008" class="csl-entry">
443. Gaitini, D., Razi, N. B., Ghersin, E., Ofer, A., &amp; Soudack, M. (2008). Sonographic evaluation of vascular injuries. <em>Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine</em>, <em>27</em>(1), 95–107. <a href="https://doi.org/10.7863/jum.2008.27.1.95">https://doi.org/10.7863/jum.2008.27.1.95</a>
</div>
<div id="ref-shaw2007" class="csl-entry">
444. Shaw, M., Del Pizzo, D. J., Pevec, W. C., Holcroft, J. W., &amp; Dawson, D. L. (2007). Case study: Cystic adventitial disease of the popliteal artery. <em>Journal for Vascular Ultrasound</em>, <em>31</em>(1), 45–48. <a href="https://doi.org/10.1177/154431670703100109">https://doi.org/10.1177/154431670703100109</a>
</div>
<div id="ref-winn2015" class="csl-entry">
445. Winn, J., Singh, C., Cloud, A., &amp; Stock, H. (2015). Radiological case: Cystic adventitial disease. <em>Applied Radiology</em>, 22–23. <a href="https://doi.org/10.37549/AR2193">https://doi.org/10.37549/AR2193</a>
</div>
<div id="ref-kremkau2021" class="csl-entry">
446. Kremkau, F. W. (2021). <em>Sonography: Principles and instruments</em> (Tenth edition). Elsevier.
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="angioaccess.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="endovascular.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": false,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": false,
"email": true
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/adam-mdmph/VS-Board-Review/blob/main/11-vascular-lab.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["_main.pdf"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true
},
"info": false
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
